Bio-Gate AG (XTER:BIG1) Interest Expense : €-0.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bio-Gate AG's interest expense for the six months ended in Dec. 2023 was € -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bio-Gate AG's Operating Income for the six months ended in Dec. 2023 was € -0.90 Mil. Bio-Gate AG's Interest Expense for the six months ended in Dec. 2023 was € -0.03 Mil. Bio-Gate AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Gate AG Interest Expense Historical Data

The historical data trend for Bio-Gate AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Interest Expense Chart

Bio-Gate AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.05

Bio-Gate AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.02	-0.03

Bio-Gate AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.05 Mil.

Bio-Gate AG (XTER:BIG1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Gate AG's Interest Expense for the six months ended in Dec. 2023 was €-0.03 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-0.90 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €0.00 Mil.

Bio-Gate AG's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Bio-Gate AG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Bio-Gate AG (XTER:BIG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BIG1:Germany BIG1:Germany

Address

Neumeyerstraße 28-34, Nürnberg, DEU

Website

http://www.biogate.de

Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.

Executives

Karl Richter

Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines